Pancreatic cancer in 2010: New insights for early intervention and detection

Nature Reviews Gastroenterology and Hepatology

Volumn 8, Issue 2, 2011, Pages 71-73

  Costello, Eithne ^a   Neoptolemos, John P ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BETA CATENIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; K RAS PROTEIN; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 12; KRUPPEL LIKE FACTOR 5; LIVER RECEPTOR HOMOLOG 1; MICRORNA; MICRORNA 200A; MICRORNA 200B; MICRORNA 21; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CHROMOSOME 12P; CHROMOSOME 6P; CHROMOSOME 7Q; CLPTM1L GENE; DNA SEQUENCE; DRUG EFFICACY; EARLY DIAGNOSIS; EARLY INTERVENTION; GENE; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMIC INSTABILITY; HUMAN; METASTASIS; MICROARRAY ANALYSIS; MOLECULAR CLONING; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TRANSCRIPTION INITIATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DNA, NEOPLASM; FLUOROURACIL; GENOMIC INSTABILITY; HUMANS; LEUCOVORIN; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VITAMIN B COMPLEX;

EID: 79751515803     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2010.214     Document Type: Review

References (10)

1. Campbell, P J. et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467, 1109-1113 (2010).
2. Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114-1117 (2010).
3. Schroder, C et al. Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies. Mol. Cell. Proteomics 9, 1271-1280 (2010).
4. Li, A. et al. Pancreatic cancers epigenetically silence SiP1 and hypomethylate and overexpress mir-200a/200b in association with elevated circulating mir-200a and mir-200b levels. Cancer Res. 70, 5226-5237 (2010).
5. Hwang, J. H. et al. identification of microrna-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS ONE 5, e10630 (2010).
6. Petersen, G. M. et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 42, 224-228 (2010).
7. Low, S. K. et al. Genome-wide association study of pancreatic cancer in Japanese population. PLoS ONE 5, e11824 (2010).
8. Li, D. & Abbruzzese J. L. new strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts. Clin. Cancer Res. 16, 4313-4318 (2010).
9. Morris, J. P 4th, Cano, D. A., Sekine, S., Wang, S. C & Hebrok, M. Beta-catenin blocks Kras-dependent reprogamming of acini into pancreatic cancer precursor lesions in mice. J. Clin. Invest 120, 508-520 (2010).
10. Neoptolemos, J. P et al. adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA 304, 1073-1081 (2010).